MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in

Rui Zhang1, Hui Luo, Shuai Wang

  • 1Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300#, Nanjing, 210029, China.

Journal of Neuro-Oncology
|September 27, 2014
PubMed

Insights

MicroRNA-622 (miR-622) suppresses malignant glioma invasion by targeting activating transcription factor 2 (ATF2). Restoring miR-622 or inhibiting ATF2 may offer new therapeutic strategies for brain tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant gliomas are aggressive primary brain tumors with poor prognoses.
  • Tumor cell invasion into surrounding brain tissue is a primary driver of treatment failure.
  • MicroRNAs (miRNAs) are emerging as key regulators of cancer cell invasion and metastasis.

Purpose of the Study:

  • To investigate the role of miR-622 in regulating glioma cell invasion and migration.
  • To identify the molecular targets of miR-622 involved in glioma progression.
  • To explore the therapeutic potential of targeting the miR-622/ATF2 axis in malignant gliomas.

Main Methods:

  • Quantitative real-time PCR to assess miR-622 expression in glioma tissues and cell lines.
  • In vitro cell invasion and migration assays (e.g., Transwell assays).
  • Luciferase reporter assays, Western blotting, and small interfering RNA (siRNA) experiments to validate ATF2 as a direct target of miR-622.

Main Results:

  • miR-622 was significantly downregulated in glioma tissues and cell lines.
  • Overexpression of miR-622 inhibited glioma cell invasion and migration; conversely, reduced miR-622 enhanced these processes.
  • Activating transcription factor 2 (ATF2) was identified as a direct target of miR-622, and its knockdown mimicked miR-622's anti-invasive effects.
  • Clinical data revealed an inverse correlation between miR-622 and ATF2 expression in glioma specimens.

Conclusions:

  • miR-622 functions as a tumor suppressor by inhibiting glioma cell invasion and migration.
  • The miR-622/ATF2 signaling axis plays a critical role in regulating glioma cell motility.
  • Targeting the miR-622/ATF2 pathway represents a promising novel therapeutic strategy for combating malignant glioma invasion.